Hongliang He - Publications

Kyasanur Forest disease virus NS3 helicase: Insights into structure, activity, and inhibitors.

Journal: International journal of biological macromolecules

Published: August 27, 2023

Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery.

Journal: Bioactive materials

Published: January 26, 2022

A biomimetic nanocomposite with enzyme-like activities and CXCR4 antagonism efficiently enhances the therapeutic efficacy of acute myeloid leukemia.

Journal: Bioactive materials

Published: November 28, 2021

Anchoring β-CD on simvastatin-loaded rHDL for selective cholesterol crystals dissolution and enhanced anti-inflammatory effects in macrophage/foam cells.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: November 23, 2021

Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions.

Journal: Biomaterials

Published: March 13, 2014

Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.

Journal: Drug delivery

Published: October 02, 2013

Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.

Journal: Biomaterials

Published: August 15, 2012

Preparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteins.

Journal: Journal of pharmaceutical sciences

Published: February 15, 2012